Sartorius Stedim Biotech S.A.
SDMHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19 | $20 | $18 | $18 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $22 | $22 | $21 | $21 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 11.2% | 0.1% | -0.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS Diluted | 0.77 | 0.69 | 0.88 | 0.47 |
| % Growth | 11.6% | -21.6% | 87.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |